Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nancy Chang Insider Profile
4 Followers
Nancy Chang, Director at Sciclone Pharmaceuticals, holds 7.64M shares in Galera Therapeutics (Ticker: GRTX), holds 38.76K shares in W&T Offshore (Ticker: WTI), holds 54.06K shares in Sciclone Pharmaceuticals (Ticker: SCLN). Most recently, Nancy Chang Bought ― shares of Galera Therapeutics on Jan 02, 2025 for an estimated value of 458.70K.
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+13.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Nancy Chang holds in companies
Most Profitable Insider Trade
Stock:
Sciclone Pharmaceuticals
(SCLN)
(SCLN)
Rating:Informative Buy
Date:Aug 19, 2014 - Aug 19, 2015
Return:+30.90%
The most profitable trade made by Nancy Chang
Nancy Chang's Trading History
Sciclone Pharmaceuticals
Oct 16, 2017
―
Uninformative Sell
782.60K
$602.76K
W&T Offshore
Jun 18, 2024
Director
Uninformative Buy
79.85K
$71.71K
Galera Therapeutics
Jan 02, 2025
Director, Ten Percent Owner
Informative Buy
458.70K
$336.38K
Charles River Labs
May 10, 2010
Director
Uninformative Buy
―
$5.07M
List of latest transactions for each holding click on a transaction to see Nancy Chang's performance on stock
You May Also Like
Nancy Chang insider profile FAQ
What is the percentage of profitable transactions made by Nancy Chang?
The percentage of profitable transactions made by Nancy Chang is 75%.
What is the average return per transaction made by Nancy Chang?
The average return per transaction made by Nancy Chang is 13.70%.
What stocks does Nancy Chang hold?
Nancy Chang holds: SCLN, WTI, GRTX, CRL stocks.
What was Nancy Chang’s latest transaction?
Nancy Chang latest transaction was an Informative Buy of $458.70K.
What was Nancy Chang's most profitable transaction?
Nancy Chang’s most profitable transaction was an Informative Buy of SCLN stock on August 19, 2014. The return on the trade was 30.90%.
What is Nancy Chang's role in Sciclone Pharmaceuticals?
Nancy Chang's role in Sciclone Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.